Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -10.65% | 6.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.65% | 6.85% | |||
| Cost of Revenue | -4.04% | 8.54% | |||
| Gross Profit | -16.00% | 5.52% | |||
| SG&A Expenses | -19.75% | -12.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.20% | -7.85% | |||
| Operating Income | 20.40% | 25.72% | |||
| Income Before Tax | 16.94% | 23.81% | |||
| Income Tax Expenses | -92.31% | -- | |||
| Earnings from Continuing Operations | 17.28% | 23.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.28% | 23.47% | |||
| EBIT | 20.40% | 25.72% | |||
| EBITDA | 18.06% | 27.21% | |||
| EPS Basic | 17.50% | 58.24% | |||
| Normalized Basic EPS | 17.17% | 58.43% | |||
| EPS Diluted | 17.50% | 58.24% | |||
| Normalized Diluted EPS | 17.17% | 58.43% | |||
| Average Basic Shares Outstanding | 0.27% | 83.25% | |||
| Average Diluted Shares Outstanding | 0.27% | 83.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
